Severe soft tissue infections

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Surgical Infections

Background:

• Severe skin and soft tissue infections (SSTIs) often necessitate intensive care unit (ICU) admission due to complications like septic shock, toxic shock syndrome, or organ failure.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a predominant pathogen in severe SSTIs, underscoring the need for targeted antimicrobial strategies.

Purpose of the Study:

• To outline fundamental management principles for severe SSTIs.
• To emphasize the critical role of early diagnosis, antimicrobial therapy, surgical intervention, and supportive care in improving patient outcomes.

Main Methods:

• The study reviews established clinical guidelines and evidence for managing severe SSTIs.
• It focuses on four key management pillars: diagnosis, antimicrobial therapy, source control, and pathogen-guided de-escalation.
• Highlights the importance of critical care interventions such as fluid resuscitation and organ support.

Main Results:

• Early differentiation between necrotizing and non-necrotizing SSTIs is crucial for guiding treatment.
• Empiric broad-spectrum antibiotic therapy, with mandatory coverage for MRSA, should be initiated promptly.
• Early and aggressive surgical source control, including debridement and drainage, significantly impacts outcomes.
• Identification of the causative pathogen allows for de-escalation of antimicrobial therapy.

Conclusions:

• A comprehensive approach integrating early diagnosis, appropriate antimicrobial selection (including anti-MRSA agents), timely surgical intervention, and robust critical care is essential for managing severe SSTIs.
• Prompt and effective management strategies are vital to reduce morbidity and mortality associated with these severe infections.